V008-1735 Screening compound: N-{3-[6-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridin-2-yl]phenyl}-3-methyl-1-benzofuran-2-carboxamide

V008-1735 Screening compound: N-{3-[6-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridin-2-yl]phenyl}-3-methyl-1-benzofuran-2-carboxamide
V008-1735 Screening compound: N-{3-[6-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridin-2-yl]phenyl}-3-methyl-1-benzofuran-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V008-1735
N-{3-[6-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridin-2-yl]phenyl}-3-methyl-1-benzofuran-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V008-1735

Molecular Formula

C29H22N2O4 (C29 H22 N2 O4)

Compound Name

N-{3-[6-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridin-2-yl]phenyl}-3-methyl-1-benzofuran-2-carboxamide

IUPAC name

N-{3-[6-(23-dihydro-14-benzodioxin-6-yl)pyridin-2-yl]phenyl}-3-methyl-1-benzofuran-2-carboxamide

SMILES

Cc1c(C(Nc2cc(-c3nc(-c(cc4)cc5c4OCCO5)ccc3)ccc2)=O)oc2c1cccc2

InChI

InChI=1S/C29H22N2O4/c1-18-22-8-2-3-11-25(22)35-28(18)29(32)30-21-7-4-6-19(16-21)23-9-5-10-24(31-23)20-12-13-26-27(17-20)34-15-14-33-26/h2-13,16-17H,14-15H2,1H3,(H,30,32)

InChI Key

RYPMHNTZHAFJQJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19952851

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

462.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.355

Distribution Coefficient, logD

6.245

Water Solubility, LogSw

-5.82

Polar Surface Area

55.751

Acid Dissociation Constant (pKa)

11.61

Base Dissociation Constant (pKb)

6.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.30

V008-1735 in Drug Discovery

Included in Screening Libraries

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V008-1735 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V008-1735?
Check Price and Availability of V008-1735, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V008-1735 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V008-1735
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V008-1735
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V008-1735 available by request